.jpg?itok=rDyKGfLP&width=2048&height=1152&impolicy=semi_dynamic "Covid pill MSD less effective than thought, 30 percent protection")
The company reports. Previously, this seemed to be the case in 50 percent of the cases. Earlier this week, MSD applied for approval from the European Medicines Agency (EMA) to market the pill in Europe.
–
–
The EMA has yet to assess the application, but has already given European governments permission to prescribe the drug.
The MSD pill is called molnupiravir and is marketed under the name Lagevrio. The drug is intended for people who have just tested positive for the virus and are at risk of becoming very ill.
–
–
People should start taking the pill within five days of the first symptoms. They then take it twice a day for five days.
Pfizer has also asked the EMA for a review of its anti-Covid pill Paxlovid.
–
–
